Selective vulnerability to perforant path stimulation: role of NMDA and non-NMDA receptors.
Penix
L P
LP
Department of Neurology, UCLA School of Medicine, USA.
Thompson
K W
KW
Wasterlain
C G
CG
D000818:Animals; D001925:Brain Damage, Chronic / Q000473:pathology / Q000503:physiopathology; D001931:Brain Mapping; D018891:Dentate Gyrus / Q000473:pathology / Q000503:physiopathology; D004292:Dominance, Cerebral / Q000502:physiology; D004827:Epilepsy / Q000473:pathology / Q000503:physiopathology*; D006624:Hippocampus / Q000473:pathology / Q000503:physiopathology*; D007395:Interneurons / Q000473:pathology / Q000502:physiology; D007696:Kindling, Neurologic / Q000502:physiology*; D008297:Male; D009416:Nerve Regeneration / Q000502:physiology; D009433:Neural Inhibition / Q000502:physiology; D009434:Neural Pathways / Q000473:pathology / Q000503:physiopathology; D009478:Neuropeptide Y / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D016194:Receptors, N-Methyl-D-Aspartate / Q000502:physiology*; D013004:Somatostatin / Q000502:physiology; D005680:gamma-Aminobutyric Acid / Q000502:physiology
D009478:Neuropeptide Y; D016194:Receptors, N-Methyl-D-Aspartate; D013004:Somatostatin; D005680:gamma-Aminobutyric Acid